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Abstract (<150 words) 
The gastric corpus epithelium is the thickest part of the gastro-intestinal tract and is rapidly turned 
over. Several markers have been proposed for gastric corpus stem cells in both isthmus and base 
regions. However, the identity of isthmus stem cells (IsthSCs) and the interaction between distinct 
stem cell populations is still under debate. Here, based on unbiased genetic labeling and biophysical 
modeling, we show that corpus glands are compartmentalized into two independent zones, with slow-
cycling stem cells maintaining the base, and actively-cycling stem cells maintaining the pit-isthmus-
neck region through a process of “punctuated” neutral drift dynamics. Independent lineage tracing 
based on Stmn1 and Ki67 expression confirmed that rapidly-cycling IsthSCs maintain the pit-isthmus-
neck region. Finally, single-cell RNA-seq analysis is used to define the molecular identity and lineage 
relationship of a single, cycling, IsthSC population. These observations define the identity and 
functional behavior of IsthSCs.  
 
  
  
Introduction 
The gastric corpus epithelium consists of long, single-layered glands populated by diverse gastric cell 
types, including pit, neck, parietal and chief cells (Bartfeld and Koo, 2017; Mills and Shivdasani, 2011; 
Willet and Mills, 2016; Kim and Shivdasani, 2016). Pit cells are located close to the stomach lumen and 
adjacent to proliferating cells in the isthmus region. Mucus neck and chief cells are located below the 
isthmus, towards the gland base. Acid-secreting parietal cells are present throughout the gland, 
except for the pit region. In common with other gastrointestinal (GI) epithelia, the corpus epithelium 
is replenished rapidly and constantly.  
As with other components of the GI tract, the corpus epithelium hosts a stem cell population in the 
gland base, marked by canonical, Wnt-responsive, stem cell markers such as Troy and Lgr5. However, 
these cells, which we term “base stem cells (BSCs)”, have characteristics distinct from stem cells in 
other GI tract components (Leushacke et al., 2017; Stange et al., 2013): during homeostasis, BSCs are 
largely quiescent and rarely contribute to the turnover of the epithelium. However, upon injury, BSCs 
proliferate rapidly and replenish the whole gland, the hallmark of a reserve stem cell population 
(Leushacke et al., 2017; Stange et al., 2013).  
In contrast to other regions of the GI tract, the corpus epithelium exhibits a unique architecture, with 
a domain of rapidly-cycling progenitors in the upper-middle part of the gland. Based on radiolabeling 
and electron microscopy (Karam and Leblond, 1993a,b,c), and later using transgene mutation 
(Bjerknes and Cheng, 2002), it was argued that this region must play host to a long-term, constantly 
proliferating, IsthSC population (Sáenz and Mills, 2018). However, this hypothesis has not been 
validated rigorously (Willet and Mills, 2016). Based on lineage tracing approaches, several stem cell 
marker genes have been proposed, including Sox2, Runx1, Lrig1, Mist1 (Bhlha15) and Bmi1 (Arnold et 
al., 2011; Choi et al., 2017; Hayakawa et al., 2015; Matsuo et al., 2017; Yoshioka et al., 2019). However, 
these markers have proved insufficient to define IsthSC identity and function. Firstly, these markers 
are not region-specific, with expression found in cells present in both isthmus and base regions, 
making the origin of long-lived clones in genetic tracing models ambiguous. Secondly, the various 
putative stem cell markers are expressed by different cells in the isthmus region with distinct 
characteristics. For example, Sox2 and Mist1 appear to mark quiescent populations, but are not co-
expressed (Hayakawa et al., 2015). Runx1+ isthmus cells are positive for the proliferation marker Ki67, 
while Mist1+ isthmus cells are Ki67- (Matsuo et al., 2017). It is also unclear which of the 
aforementioned markers correlate with Lrig1+ isthmus cells (Choi et al., 2017). Importantly, it remains 
uncertain as to whether these markers are co-expressed by individual cell types or mark different 
corpus cell types. Due to these uncertainties, the existence, identity, multiplicity and potency of 
IsthSCs are widely considered to be unresolved issues. Indeed, it is still not clear whether IsthSCs are 
quiescent or active, or whether they constitute a long-lived population or a transient descendent of 
BSCs. 
To define the identity and function of IsthSCs, we have used an unbiased, marker-free, lineage tracing 
approach, combining ubiquitous labeling with the multi-color confetti mouse reporter system 
(Snippert et al., 2010). Our findings reveal that there are two distinct stem cell populations governing 
the upper and lower parts of gastric corpus glands. Analysis of the clonal dynamics reveals a process 
of “punctuated” neutral drift in the isthmus region, showing that actively-cycling IsthSCs serve as the 
main source of tissue turnover. Using lineage tracing strategies based on the expression of the 
proliferation markers Stmn1 and Ki67, we confirmed the actively-cycling nature of the IsthSC pool. 
Finally, we used single-cell (sc)RNA-seq analysis to define the molecular heterogeneity and lineage 
relationship of isthmus cells, confirming a broad expression signature of IsthSC marker genes. These 
  
findings show that rapidly-cycling cells in the isthmus region function as the definitive IsthSC 
population governing the turnover of the pit-isthmus-neck region of the corpus gland.   
 
Results 
Stomach corpus glands are maintained by two independent stem cell populations 
Based on the current literature, clonogenic activity is expected to occur in two regions of the gastric 
corpus gland: one is located in the (proliferatively-active) isthmus region and the other is in the gland 
base (Phesse and Sansom, 2017; Willet and Mills, 2016). However, the potential lineage relationship, 
potency and function of these populations is still debated (Figure 1A). To probe the long-term fate of 
isthmus cells, we sought to define the clonal dynamics of individual lineages in corpus glands using 
the 4-color (green, yellow, red and cyan) Rosa26-StopFlox-Confetti (R26R-Confetti) reporter system 
and a ubiquitously expressed CreER allele. Using deep-tissue imaging (Figure S1), together with 
nuclear (DAPI) and plasma membrane staining (β-catenin), we resolved clones at single cell resolution 
throughout the entire corpus region over a 3 month time course. Among various ubiquitous, inducible 
Cre lines, we settled on the Rosa26-CreERT2;R26R-Confetti mouse as optimal (Figure S2). Then we 
performed long-term lineage tracing using the Rosa26-CreERT2;R26R-Confetti mouse up to 1.5 years 
(Figure 1B and 1C).  
At 2 weeks (w) post-tamoxifen (TAM) administration, large isthmus-localized clones were readily 
identifiable, while smaller clones lay scattered throughout the base (Figure 1C). After 3 months (m), 
base clones had begun to expand, while remaining base-localized (Figure 1C, red arrowheads), while 
isthmus-spanning clones were restricted to the upper part of the gland (Figure 1C, green arrowheads). 
This pattern of behavior – isthmus-spanning upper clones and base-localized small clones –  prevailed 
over the entire time course. Charting the length and center of clones (Figure 1D), we found evidence 
for their progressive segregation into two types (Figure 1E). On average, an isthmus-spanning clone 
occupied some 80% (± SD20%) of the whole gland in the upper region, while a base-localized clone 
occupied some 30% (± SD10%) at 18 m post-induction (Figure S2G and S2H), supporting a scenario in 
which individual corpus glands are maintained by two equally long-lived, but distinct, stem cell 
compartments (Figure 1A, center).  
At high doses, TAM can lead to damage of parietal cells (Huh et al., 2012) that, in turn, can cause 
proliferation in the base (Leushacke et al., 2017); in this context, the vertical lengths of base clones 
were relatively high as compared to those reported by Leushacke et al., 2017, most likely due to the 
higher dose of TAM (3mg/20g mouse body weight). However, notably, in both our current study and 
that of Leushacke et al., after an initial burst of proliferation in the base following induction, base 
clones show the same low degree of expansion over the long term (Figure S2G, cf. the fast vertical 
expansion of upper clones, Figure S2H). This suggests that the early expansion represents a transient, 
damage-mediated response to TAM. However, the limited extent of expansion, and its subsequent 
arrest, suggests that marked cells at the gland base do not make a long-term contribution to the 
isthmus region, supporting the inferred compartmentalization of tissue. To reinforce this conclusion, 
we also examined clonal organization in the Rosa26-rtTA;tetO-Cre;R26R-Confetti system. Notably, 
based on this doxycycline-mediated labelling strategy, traced over 3 m, the pattern of tracing was 
almost identical to that of the Rosa26-CreERT2;R26R-Confetti model (Figure S2I and S2J), confirming 
the existence of two long-lived, but distinct, compartments. 
Previously, it has been shown that individual clones spanning the entire gland can emerge under 
conditions of injury and repair (Leushacke et al., 2017; Stange et al., 2013). In the current analysis, it 
  
was notable that very few clones (~2.4% at 18 m post-induction) occupy entire glands (Figure 1E), 
indicating the longevity of both compartments under homeostatic conditions.  
 
The pit-isthmus-neck region of the stomach corpus gland is maintained by stochastic loss and 
replacement of IsthSCs 
To understand the behavior of isthmus-derived clones, we analyzed their dynamics based on their 
vertical and lateral expansion around the gland by performing whole mount imaging following deep 
tissue labeling (STAR Methods). Previously, quantitative studies of clonal dynamics in the mouse small 
intestine and colon have shown that turnover is supported by the competition of intestinal stem cells 
(ISCs) for niche access at the crypt base, as evidenced by the “neutral drift dynamics” of stem cell-
derived clones (Lopez-Garcia et al., 2010; Snippert et al., 2010; Ritsma et al., 2014). Based on the rapid 
vertical expansion of isthmus-derived clones (Figures 1C and 1F) and their cohesive character, we 
expected that neutral competition between actively-dividing IsthSCs would drive a similarly rapid 
lateral drift of clones around the circumference of the isthmus, mirroring the clonal dynamics of the 
crypt. However, over the long-term, partially-labeled isthmus regions (Figure 2A-I) were found to be 
much more abundant than fully labeled regions (Figure 2A-II): when quantified by the angular span of 
isthmus clones (Figure 2B and Movie S1), we found that it took 3 m for the average clone size to extend 
to more than 50% of the gland circumference. Even at 12 m, some isthmus regions remained only 
partially-labeled (Figure 2C and 2D), suggesting that the drift of clones toward monoclonality in the 
isthmus region is unexpectedly slow given the seemingly rapid rate of cell division in this region as 
evidenced by the vertical clone expansion.  
To explain this behavior, we first considered whether the medium- and long-term dynamics of isthmus 
clones were consistent with the labelling of a renewing population. Indeed, after an initial abrupt loss 
of clones derived from cells with short-term proliferative potential, the steady increase in average 
clone size (Figure 2C) was compensated by a decrease in clone persistence (Figure 2E) so that the 
average fraction of labeled cells remained approximately constant over the time course (Figure 2F), 
i.e. by 3 m post-labelling, clones are enriched in those derived from stem cells with long-term renewal 
potential.  
To understand the dynamics of lateral clonal expansion, we first invoked a stochastic model of stem 
cell fate describing lateral cell competition in the isthmus region. Our starting point was the 
“orthodox“ model of neutral drift introduced to describe clonal dynamics in the intestinal crypt 
(Lopez-Garcia et al., 2010). In this model, stem cell division is correlated with the displacement of 
neighbors from their niche and their entry into a differentiation program, so that the size of the stem 
cell compartment remains constant over time. In the intestine, the localization of the stem cell 
compartment to the crypt base leads to a unidirectional displacement of differentiated cells, resulting 
in a rapid vertical expansion of clones along the crypt axis and a slower lateral expansion around the 
circumference. In the context of the stomach corpus, the association of the stem cell niche with the 
isthmus domain leads to an unusual bidirectional displacement of cells both upwards into the pit and 
downwards into the neck region (Figure 1A).  
Within this framework, the clonal dynamics depends in principle on two parameters: the rate of IsthSC 
division and the frequency with which such divisions lead to stem cell loss and replacement around 
the gland. However, since our focus is on the slow lateral expansion of clones, inspired by studies of 
the intestinal crypt, we considered a simpler one-parameter model in which the IsthSC compartment 
is characterized by a one-dimensional chain of cells in which, at rate 𝜆, loss through displacement and 
  
differentiation is compensated by the symmetric division of a neighbor (for details, see STAR 
Methods). Note that such a model represents a caricature of what is likely to be a more complex 
organization in which the long-term survival potential may be biased or primed by location within the 
niche, so that the “effective” IsthSC number, 𝑁, may underestimate the number of IsthSCs that have 
the potential to support long-term self-renewal (Ritsma et al., 2014). 
From the measurements of average clone size, we found that the neutral drift model could provide a 
satisfactory fit to the data (Figure S3A) with a stem cell loss/replacement rate of 𝜆/𝑁2 = 0.03/month. 
Indeed, this ratio is some four times slower than that reported in the intestinal crypt (Lopez-Garcia et 
al., 2010). Moreover, if we equate 𝑁  with the typical number of dividing isthmus cells within a 
circumferential section of the gland (estimated at around 8), this ratio translates to a loss/replacement 
rate of around once per 2 weeks, a figure much lower than the expected cell cycle time of IsthSCs.  
 
Parietal cells establish a barrier to the lateral expansion of isthmus clones 
Despite the apparent viability of the neutral drift model, such a slow rate of IsthSC loss/replacement 
seemed incompatible with both the rapid vertical clonal expansion (Figure 1F) and the rapid early 
lateral expansion of some clones around the gland circumference (Figure 2C). Indeed, the invariance 
of the average labeled cell fraction over the long term (Figure 2F) suggested that the initial rapidly-
expanding clones are likely to be precursors of “long-term” clones at later time points. Therefore, to 
resolve the paradoxical anisotropy in the dynamics of clonal expansion, we searched for constraints 
in the cellular organization that might present barriers to lateral clonal expansion. High-resolution 3D 
reconstruction of the isthmus compartment (Figure 3A) revealed an ordered spatial organization of 
parietal cells (HKATPase, in green) and cycling progenitors (Ki67, in red) within the isthmus region. 
Small Ki67+ progenitors were located between columns of larger, non-dividing parietal cells that 
tightly share their plasma membranes along the length of the gland to form a structure that is 
approximately vertically aligned – an apparent “wall” of parietal cells (Movie S2). The intercalation of 
Ki67+ cells between walls of long-lived parietal cells suggested that the latter may act as physical 
barriers against the lateral expansion of stem cell-derived clones in the isthmus region (Figure 3B).  
To assess this possibility, we eliminated parietal cells by DMP-777 treatment (Goldenring et al., 2000; 
Nam et al., 2010; Nomura et al., 2005), while performing Rosa26-CreERT2;R26R-Confetti labeling and 
lineage tracing. One oral administration of DMP-777 (7 mg/20 g body weight) was sufficient to induce 
acute loss of parietal cells, which were almost completely restored within 2 weeks (Figure S3B and 
S3C). This acute tissue damage resulted in no major change to the isthmus vs. base lineage tracing 
pattern of clonal compartmentalization (Figure S3D). By contrast, lateral clonal expansion was found 
to be faster at 3 m post-parietal cell depletion, resulting in fewer partially-labeled glands (Figure 3C): 
in DMP-777-treated mice, almost half of all clones (47%) reached monoclonality in the isthmus region 
by 3 m post-induction, compared to only 23% at the same time point in the control (Figure 3D). Indeed, 
it took more than 6 m for control samples to contain more than 50% of glands with monoclonal 
labeling in the isthmus region (Figure 2D). Together, these results indicate that the transient loss of 
parietal cell barriers allows IsthSCs to achieve a faster lateral drift around the gland circumference. 
Based on this observation, we developed a minimal refinement of the neutral drift model, where rapid 
lateral stem cell loss-and-replacement is obstructed by long-lived barriers (parietal cells) which are, in 
turn, sporadically lost and replaced. In this model of “punctuated” neutral drift, transient parietal cell 
loss opens a window for lateral expansion (Figure 4A, see STAR Methods), allowing isthmus clones to 
expand in “bursts” around the circumference of the gland. To constrain the model, we used cross-
  
sectional images of Confetti-labeled glands (Figure S3F) to quantify the number of parietal cells (Figure 
4B) and their angular distances within the isthmus (Figure 4C and S3G), finding that each cross-section 
hosted 2 or 3 parietal cells. Strikingly, parietal cells appeared not to be randomly positioned, but were 
preferentially located at maximum angular distances from each other around the circumference of 
the gland (Figure 4C and S3G). We incorporated this observation into our model by demanding that, 
when born sporadically, barrier segments (viz. parietal cells) would tend to maximize the distance 
between each other. Based on the inferred dynamics, we questioned whether the model could predict 
the number distribution and relative positions of parietal cells. By tuning the relative rates of parietal 
cell loss and replacement, we found that we could constrain the predicted distributions of the 
numbers (Figure 4B) and relative positions (Figure 4C and S3G) of parietal cells to those observed 
experimentally (STAR Methods). 
We then challenged whether the difference in the dynamics of lateral expansion between the control 
and DMP-777 model could be due solely to the presence/absence of parietal cells in the early phase 
of lateral clonal expansion. Since DMP-777 treatment temporarily removes parietal cells, we reasoned 
that the recovery phase would provide an extended window in which isthmus clones could expand 
laterally. The remaining model parameters were determined from average properties of clones and 
glands in both control and DMP-777 experiments which, in the model, are represented by different 
initial conditions for the presence/absence of barrier segments (STAR Methods). Using only 7 data 
points (viz. average clone sizes in Figure 4D, 4F and S3I) to determine the parameters, we could fit the 
whole range of clone behaviors, from the dynamics of average clone expansion and loss, to the size 
distribution and accumulation of monoclonal glands (Figure 4E, 4G, S3J and S3K). In particular, the 
model of punctuated neutral drift provided an intuitive explanation for the changing speed of effective 
clonal expansion, with rapid early growth within parietal barriers leading to the slower growth phase 
across boundaries (Figures 1F and 4D). Within this paradigm, the loss-and-replacement rate of isthmus 
cells, 𝜆/𝑁2 = 0.3/month, was some ten-fold faster than that inferred from the orthodox neutral drift 
model, while the inferred lifetime for barrier segments in the range of a few months was compatible 
with the expected lifetime of parietal cells (for which an average lifespan of about 54 d has been 
reported in mice; Karam, 2010). Importantly, this model resolves the paradoxical anisotropy of clone 
expansion and, in common with ISCs, predicts that the loss-and-replacement rate of IsthSCs is 
comparable to their cell cycle rate.  
To further challenge the model, and rule out the possibility that accelerated lateral expansion under 
DMP-777 treatment may be due to the effect of injury on IsthSC proliferation, we considered the 
effect of a perturbation that could discriminate between vertical and lateral clonal expansion. In the 
orthodox model, the major determinant of lateral clone expansion is the stem cell loss/replacement 
rate, a property of the stem cell compartment. As depicted in Figure S4A-S4D, if the loss/replacement 
rate increases, the lateral clone expansion is accelerated (Figure S4C and S4D), leading to faster clone 
fixation of the gland as compared to the control (Figure S4B and S4D). However, in the punctuated 
drift model (Figure S4E-S4J), an increased loss/replacement rate results in more or less the same rate 
of angular clonal expansion (Figure S4G and S4H) as compared to the control (Figure S4F and S4H), 
while enhancing the speed of vertical clone expansion (Figure S4G). By contrast, a decreased parietal 
cell lifespan (or, indeed, transient parietal cell loss by DMP-777) can cause accelerated lateral clone 
expansion (Figure S4I and S4J) as compared to the control (Figure S4F and S4J), while not affecting the 
vertical expansion dynamics (Figure S4I), a behavior consistent with our data (Figure S3D). It therefore 
follows that the dynamics of IsthSCs in the punctuated model is determined by the physical properties 
of the niche, not by intrinsic competition within the stem cell compartment alone. 
  
To validate the different predictions of the two models, we made use of the Muc6-DTR;Rosa26-
CreERT2;R26R-Confetti system (Figure S5A). Since Muc6 is a marker for neck cells (positioned close to 
IsthSCs), we could specifically deplete neck cells upon diphtheria toxin (DT) administration while 
preserving parietal cells (Figure S5B-S5D), which results in an injury response of IsthSCs as well as BSCs 
(Figure S5E). In this case, if the injury itself were the main reason that the lateral expansion is 
accelerated, rather than the loss of parietal cells, we should also observe increased lateral expansion 
of the isthmus-anchored clones in Muc6-DTR;Rosa26-CreERT2;R26R-Confetti mice treated with DT, 
even in the presence of the parietal cell barrier. Therefore, we treated mice with DT at 1 w post-
induction by TAM. The degree of neck cell depletion by DT (Figure S5F and S5G) was significant and, 
by degree, comparable to that of parietal cell loss by DMP-777 treatment (Figure S3B and S3C). Mice 
were examined at 1 m post-TAM induction (viz. 3 w post-DT treatment). We found that the vertical 
expansion of isthmus clones was significantly increased with DT treatment compared to controls 
(Figure 4H and 4I), while the lateral expansion of isthmus clones was almost the same (Figure 4J and 
4K), consistent with the punctuated drift model (Figure S4G, S4H and S5H). These findings confirm 
that it is the removal of parietal cell barriers that results in accelerated lateral expansion of clones in 
the DMP-777 experiment. 
 
Rapidly cycling isthmus progenitors can maintain long-term self-renewal potential  
Based on the proliferative activity of IsthSCs, we then searched for reliable markers to characterize 
actively-cycling cells in the gastric isthmus. To this end, we employed the fluorescent ubiquitination-
based cell cycle indicator (Fucci) ubiquitous mouse model (Rosa26-Fucci2a) to isolate proliferating 
isthmus cells for expression analysis (Mort et al., 2014). This mouse model utilizes the reciprocal 
degradation during the cell cycle of truncated forms of Cdt1 (hCdt1(30/1/20)) and Geminin 
(hGem(1/110)) fused to the fluorescent proteins Venus (green) and Cherry (red), respectively (Figure 
5A). The green signal (mVenus-hGem(1/110)) marks cells in S-G2-M phase. In the stomach corpus 
epithelium, the Fucci mouse indicated a prominent band of proliferating progenitors marked by green 
signal in the isthmus region (Figure 5B). Using FACS, we isolated S-G2-M phase cells (R3, Venus+) from 
the epithelial cell fraction (R2, E-Cadherin+) (Figure S6A) and performed bulk RNA-seq analysis. By 
integrating this bulk RNA-seq data with additional criteria, we identified two marker candidates for 
the actively-cycling isthmus progenitor population (Figure 5C and Figure S6B; see STAR Methods). One 
candidate was the widely-used proliferation marker, Mki67 (Ki67), and the other was Stathmin1 
(Stmn1), the expression of which were confirmed by immunohistochemistry and in situ hybridization, 
respectively (Figure 5D).  
To validate our hypothesis that the proliferating isthmus progenitor population includes IsthSCs, we 
generated a Stmn1-P2A-eGFP-IRES-CreERT2 mouse line (Figure 5E). eGFP expression of Stmn1-P2A-
eGFP-IRES-CreERT2 (Stmn1-iCre) mice was highly specific to Ki67+ proliferating isthmus progenitors 
(Figure 5F). We checked that there was no induction in Stmn1-iCre mice without TAM treatment 
(Figure S6C). Upon TAM administration, clones induced by the Stmn1-iCre model began to appear in 
proximity to the isthmus region with rapid migration and (bidirectional) expansion of clones (Figures 
5G and S6D). Only a small fraction of clones was observed in the base region (Figure S6D), most likely 
arising from the rare proliferative activity of slowly-cycling chief cells at the time of induction. At 
subsequent time points (0.5-6 m), Stmn1-iCre-labeled clones exhibited long-term lineage tracing in 
the upper part of corpus glands, generating pit, neck and parietal cells (Figure 5G and 5H). 
Mki67tm2.1(cre/ERT2)Cle;R26R-RFP (Ki67-iCre)-mediated tracing experiments also yielded similar long-term, 
pit-isthmus-neck spanning clones up to 6 m post-induction (Figure S6E). The isthmus clones in Ki67-
iCre lines also showed slow lateral expansion, as observed from the ubiquitous promoter, while DMP-
  
777-mediated depletion of parietal cells resulted in accelerated drift (Figure S6F and S6G). Together, 
these results provide further evidence that actively-cycling cells in the isthmus contain IsthSCs.       
 
scRNA-seq analysis defines the molecular signature and lineage relationships of IsthSCs 
To identify cells with IsthSC characteristics within the Stmn1+ isthmus population, we performed 
scRNA-seq analysis with sorted Stmn1-GFP+ cells (Figure S6H). We identified 9 clusters using 
consensus-based clustering (Kiselev et al., 2017) (Figure 6A). 46% of cells (cluster 4-7 in Figure 6A) 
were classified as belonging to the Stmn1high population while others (cluster 1-3, 8 and 9 in Figure 6A) 
were  Stmn1low (Figure 6B, upper left panel). The appearance of the latter pool is likely a reflection of 
the stability of the eGFP protein, suggesting that Stmn1high cells are precursors of Stmn1low cells. Ki67 
expression largely overlapped with Stmn1 (Figure 6B, lower left panel), confirming that the Stmn1+ 
and Ki67+ populations are nearly identical at the transcriptional level and mark highly proliferative 
cells (Figure S7A).  
Based on the expression of cell cycle phase-specific genes in the t-distributed stochastic neighbor 
embedding (t-SNE) plot, the Stmn1high population could be partitioned largely into two subpopulations 
marked by expression of Cdt1 (G1/early S) and Ccnb1 (G2/M) (Figure 6B, middle panels and Figures 
S7B-D). By contrast, the Stmn1low population could be cleanly segregated by the expression of pit 
(Muc5ac) and neck (Muc6) markers (Figure 6B, right panels and Figures S7E and S7F) implying that, 
depending on their differentiation path, Stmn1low cells migrate upwards or downwards from the 
isthmus region to become pit and neck cells, respectively. This became even more obvious in the 
pseudotime analysis (Figure 6C), showing divergent differentiation trajectories of the Stmn1high 
population toward pit or neck cell fates (Figure 6C, 6D, S7G and S7H; see STAR Methods). 
Alongside the strong cell cycle signature (Figure 6B), the Stmn1high cluster showed heterogeneous, but 
structured, expression of the differentiation markers Muc5ac and Muc6, with cells belonging to the 
four groups: 1) Cdt1high Muc5achigh, 2) Ccnb1high Muc5achigh, 3) Cdt1high Muc6high and 4) Ccnb1high 
Muc6high (Figure S7I). We reasoned that expression of these differentiation markers within the 
actively-cycling population may be evidence of early sublineage restriction of progenitors. Based on 
this observation, we regressed out the cell cycle signature (Butler et al., 2018). As a result, the 
Stmn1high cluster segregated into 6 subclusters (S1-S6) (Figure 6E and 6F), showing different degrees 
of bias towards pit or neck cell lineages (Figure 6G). We then measured the distance between each 
cell in the Stmn1high cluster and neck and pit cells based on their correlation of gene expression (see 
STAR Methods). From this analysis, we found that subclusters S2 and S3 have higher correlation with 
pit cells than neck cells, with the degree and statistical significance of the bias indicated by p-values < 
0.01 (Figure 6G). Conversely, subcluster S6 showed a higher correlation with neck cells than pit cells 
(Figure 6G). This suggests that these three subclusters constitute progenitor populations that have 
already become restricted to the respective sublineages. Subclusters S1, S4 and S5 had relatively 
unbiased signatures with respect to neck and pit cell lineages, implying that these might constitute 
the undifferentiated stem cell compartment. However, even with the overall pattern of bias towards 
pit or neck cell sublineages, cells in subclusters S1-S6 were almost evenly spread along the diagonal 
line of the pit-neck cell correlation spaces, indicative of transcriptional heterogeneity within the 
individual subclusters (Figure 6G). 
To confirm the correlation analysis and refine the distinction between the subclusters, we performed 
pseudotime analysis for the 6 subclusters (STAR Methods). Accordingly, we inferred two distinct 
lineages: 1) S4 o S5 o S1 o S2 o S3 leading to the pit cell lineage, and 2) S4 o S5 o S1 o S6 leading 
  
to the neck cell lineage (Figure 6H). Next, we examined changes in gene expression along the 
pseudotime trajectory to define molecular signatures of the putative IsthSC and progenitor 
compartments. Distinct expression patterns were found that peak in early or late phases of the 
pseudotime trajectory (Figure 6I and Table S4). Differentiation-associated marker gene expression 
(viz. Muc5ac and Muc6) indicated that cells in the pseudotime trajectory progress toward 
differentiation. Some genes showed enriched expression in the putative IsthSC clusters (S4 and S5), 
including Cib1, Ndufb8 and Psma7 (Figure 6I), though their expression patterns were not exclusive to 
the isthmus compartment. Moreover, the activation of canonical stem cell signaling pathways such as 
Wnt or Notch were not observed in the IsthSC clusters (S4 and S5).  
To corroborate the results of the scRNA-seq analysis, we examined the spatial organization of cells 
based on the expression patterns of defined clusters. To this end, we used RNAscope (Wang et al., 
2012) to determine the expression pattern of Muc5ac, Muc6 and Ki67. As predicted from the single-
cell data, Ki67+ cells in the isthmus region showed robust expression of Muc5ac or Muc6, consistent 
with sublineage-restricted progenitors. Notably, between these domains, we found Ki67+ cells 
showing low levels of co-expression of both Muc5ac and Muc6, consistent with the uncommitted 
nature of the putative IsthSCs identified by scRNA-seq (Figure 6J). These results indicate that cells in 
subclusters S4 and S5 are located in the isthmus center, consistent with a model in which centrally-
located IsthSCs support bidirectional output of differentiating progeny. 
Lastly, we analyzed well-known gastric markers in the scRNA-seq data of Pgc+ gastric corpus chief cells 
sorted from Pgc-IRES-DTR-T2A-dsRed knock-in mice (Figure S7J and S7K). Although it is primarily 
known as a chief cell marker, Pgc was found to be broadly expressed in many different gastric cell 
types except parietal cells. Based on cell type-specific markers, the t-SNE plot recapitulated the 
anatomical localization of the stomach corpus gland with chief cells at the base, neck cells in the lower 
middle part and pit cells at the top of the gland (Figure S7L). Both Ki67+ and Stmn1+ populations form 
a highly specific group of cells, and Lgr5+ cells are within the Gif+ chief cell domain, as recently 
reported (Leushacke et al., 2017) (Figure S7M). However, other markers, such as Sox2, Runx1, Lrig1, 
Mist1 (Bhlha15) and Bmi1, showed a very broad pattern of expression in our single-cell data (Figure 
S7M).  
 
Discussion 
Based on the analysis of clonal data (in normal and perturbed states) and single-cell profiling, we 
propose a unified framework in which the epithelium of gastric corpus glands are maintained by two 
distinct stem cell populations: an actively proliferating stem cell population in the isthmus region with 
a broad expression signature, and a quiescent reserve stem cell population in the base, marked by 
expression of Troy and Lgr5 (Figure 7). Although the existence of a quiescent IsthSC population cannot 
be ruled out, quantitative analysis of clonal fate data demonstrates that actively-cycling, multipotent, 
IsthSCs are capable of long-term self-renewal.  
Through a process of “punctuated” neutral drift, our results show that the loss-and-replacement of 
IsthSCs leads to rapid vertical clone expansion, while the lateral expansion of clones is impeded, as 
previously observed (Nomura et al., 1998), by the physical barrier of long-lived parietal cells. Only 
when a parietal cell is lost can clones expand laterally around the gland circumference, leading 
eventually to clonal fixation of the isthmus region. Indeed, this behavior echoes that reported in 
human colon (Stamp et al., 2018; Nicholson et al., 2018), suggesting that a similar barrier-inhibited – 
or punctuated – drift mechanism may be operative in other glandular contexts. Although the function 
  
of barrier restriction is unclear, the geometric arrangement of parietal cells may prevent them from 
being “pushed out” into the lumen by the tide of migrating Muc5ac+ differentiating cells during the 
course of homeostatic turnover.  
To address the molecular identity of corpus stem cells during homeostasis, we generated scRNA-seq 
data from Stmn1-GFP+ cells containing both proliferating IsthSCs and their early differentiating 
progeny. We found evidence for substructure within the Stmn1high cluster, which allowed us to 
abstract a restricted stem cell signature as well as relationships between IsthSCs and their immediate 
sublineage-restricted progenitor cell progeny. Our findings do not reveal an exclusive and definitive 
stem cell marker: rather, we find genes that are enriched in, but not exclusive to, IsthSCs. These results 
suggest that, as in the intestinal crypt (Ritsma et al., 2014), the stem cell signature may be broad, with 
varying degrees of renewal potential linked to exposure to localized niche factors associated with 
neighboring epithelial and/or stromal cell types. As IsthSCs divide, others may become displaced from 
the niche region, moving down into the neck region or up towards the pit region, becoming sublineage 
restricted to the neck or pit cell lineages. Future studies must target the origin and repertoire of such 
niche factors that support the self-renewal activity and multipotency of the IsthSC compartment. 
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Figure legends 
Figure 1. Stomach corpus glands are maintained by two independent stem cell populations. 
(A) Schematic illustrating potential outcome of clonal expansion in stomach corpus glands based on 
the long-term contribution of isthmus and base stem cells. Left panel: slowly-cycling base stem cells 
replace isthmus progenitors over time. Middle panel: isthmus and base stem cells maintain their 
respective compartments over time. Right panel: IsthSCs replace base stem cells over time. 
(B) Experimental schedule for tracing. 
(C) Representative images from 150 µm-thick z-stack confocal images of stomach corpus of Rosa26-
CreERT2;R26R-Confetti mice at 2 w, 3 m, 6 m, 1 year (y) and 1.5 y following injection of TAM. Isthmus- 
and base-localized clones are indicated by green and red arrowheads, respectively. Yellow: EYFP; Red: 
tdimer2; Cyan: mCerulean; Grey: β-Catenin; Blue: DAPI. Scale bars: 50 µm. 
(D) Schematic illustrating the quantification of clone characteristics based on the midpoint and length. 
Scale bar: 50 µm. 
(E) Scatter plot of relative (vertical) clone length and center position in Rosa26-CreERT2;R26R-Confetti 
mice. Clone characteristics illustrate a separation over time into larger clones (inside red dotted 
ellipse) located in the isthmus/pit region and smaller clones (inside yellow dotted ellipse) located in 
the base region of glands. Approx. 100 clones from n=2 mice used per time point. 
(F) Distribution of the relative length of labeled clones in the isthmus region to gland length over time 
based on Rosa26-CreERT2;R26R-Confetti tracing. Dots denote individual clone lengths. Red line: mean; 
red-shaded box: 95% confidence interval (CI); blue-shaded box: standard deviation (SD). 
See also Figures S1 and S2. 
 
Figure 2. The isthmus/pit region of the stomach corpus gland is maintained by stochastic loss and 
replacement of IsthSCs. 
(A) Representative whole mount image of stomach corpus from Rosa26-CreERT2;R26R-Confetti mice 
at 3 m post-induction. Ki67 antibody staining of proliferative cells (green) identifies the isthmus zone. 
Magnified panels to the right show examples of partially (I) and fully (II) labeled glands. Yellow: EYFP; 
Red: tdimer2; Green: Ki67; Grey: β-Catenin; Blue: DAPI. Scale bars: 25 µm. 
(B) Scoring strategy to quantify lateral clone expansion by measuring the relative angular size of clones 
around the gland circumference. Relative angular size was measured in pit, isthmus and neck regions 
at 3 m post-induction. 
Left panel: schematic showing the contribution of a yellow isthmus clone. The 3 sections depict the 
top (Isthmus 1), center (Isthmus 2) and lowest (Isthmus 3) position of the isthmus zone, as defined by 
Ki67 labeling. 
Right panel: in each optical section, the clone dimensions are defined by 3 points (P1, P2, P3 and 
connecting white lines), which determine the angular clone size. 
(C) The relative angular clone size of isthmus clones at 2 w, 3 m, 6 m and 12 m post-induction. Black 
dots represent individual clones. Green dots are the average values for each time point, with the 
  
dotted line linking the average values to show the trend over time. All measurements obtained from 
n=3 mice. 
(D) Percentage of fully and partially-labeled glands at indicated time points. 
(E) Clone survival curve for isthmus-labeled glands. The frequency was calculated from the number of 
glands labeled in the isthmus region relative to the total number of glands for n=3 mice at each time 
point. 
(F) Average fraction of labeled isthmus cells at indicated time points. 
See also Movie S1 and Figure S3. 
 
Figure 3. Parietal cells act as physical barriers against lateral clone expansion. 
(A) Representative confocal (63x) image of the pit-isthmus-neck region from 150 µm-thick section of 
mouse stomach corpus illustrating cellular organization (I). 3D reconstruction of the confocal z-stack 
images was performed using IMARIS (Bitplane) (II). Small, Ki67+ cells are tightly packed between 
columns of large HKATPase+ parietal cells, suggesting that the lateral expansion of Ki67+ cells may be 
inhibited. Red: Ki67; Green: HKATPase; Grey: β-Catenin. 
(B) Schematic depicting potential role of parietal cells as barriers to lateral expansion in the isthmus 
region. From the gland architecture, progeny of Ki67+ proliferating cells may move vertically (parallel 
to the gland axis) through the “valley” formed between parietal cells, resulting in rapid vertical 
expansion (left diagram). By contrast, the lateral expansion of Ki67+ cell progeny is blocked by long-
lived parietal cells (green) acting as physical barriers, resulting in slow lateral expansion (right 
diagram).  
(C) Experimental timeline and representative images of whole mount tissue from Rosa26-
CreERT2;R26R-Confetti mouse corpus with (right) and without (left) administration of DMP-777. The 
white dotted lines indicate partially-labeled glands. The relative number of partially-labeled glands 
was reduced in the DMP-777-treated sample. Yellow: EYFP; Red: tdimer2; Green: Ki67; Grey: β-
Catenin; Blue: DAPI. Scale bars: 50 µm. 
(D) The percentage of partially-labeled glands in untreated and DMP-777-treated samples was 
quantified at 3 m post-induction. n=3 mice for each condition. 
See also Movie S2 and Figure S3. 
 
Figure 4. Parietal cells establish a barrier function inhibiting the lateral expansion of isthmus clones. 
(A) Schematic of two possible models: orthodox neutral drift model (upper panel) and the 
“punctuated” neutral drift (PND) model (lower panel). In the orthodox model, loss-and-replacement 
of neighboring stem cells leads to a slow drift of clones around the gland circumference. In the PND 
model, stem cell loss-and-replacement occurs rapidly in the region between parietal cells (PCs), 
leading to an expanded clone which persists in the region between the parietal cells. However, the 
loss-and-replacement of stem cells between neighboring regions is blocked by the long-lived parietal 
cells. If the barrier is removed through the death of a parietal cell, clonal expansion can occur again, 
leading to a burst of expansion in the manner of a punctuated drift. 
  
(B) Distribution of PCs per gland section in the isthmus region. Sky blue dots and lines indicate means 
and SD derived from model simulations and dark blue bars indicate experimental data.  
(C) Distribution of minimum relative angular distance between PCs for a value of 2 PCs per gland 
isthmus region. The minimum angular distance is the smallest angle between a pair of PCs. Sky blue 
dots and lines indicate means and SD derived from model simulations and dark blue bars indicate 
experimental data. 177 glands from n=2 mice used for (B) and (C). 
(D-G) Relative angular clone size for control (D) and DMP-777-treated (F) samples at indicated time 
points. Box plots represent experimental data for each condition. Solid lines represent the fit of 
simulated results using the PND model with and without incorporation of PCs as physical barriers, with 
the same model parameters but different initial conditions. Cumulative fraction of the relative angular 
clone size at indicated time points for control (E) and DMP-777-treated samples (G). Dots indicate the 
frequency as determined from experimental data. Lines indicate the fit of simulated results from the 
PND model with and without incorporation of PCs as physical barriers, with the same model 
parameters but different initial conditions. Shading displays the 95% CI around the fit of simulated 
data. All measurements were obtained from n=3 mice. 
(H, J) Representative images of vertical sections (H) and whole mounts (J) of mouse stomach corpus 
glands in the Mu6-DTR;Rosa26-CreERT2;R26R-Confetti line with or without DT at 1 m post-labelling. 
Yellow: EYFP; Cyan: mCerulean; Blue: DAPI. Scale bars: 50 µm.  
(I, K) The relative length (I) and angular size (K) of the isthmus-anchored clones in the same samples 
as (H) and (J). Red line: mean; red-shaded box: 95% CI; blue-shaded box: SD. *p-value < 0.05. N.S.: 
statistically not significant (p-value > 0.1). Two-sample Kolmogorov-Smirnov test used. Clones from 
n=2 mice analyzed. Note that in the vertical sections the red clones were not counted to avoid 
confusion with the dsRed signal from the Muc6-IRES-DTR-T2A-dsRed allele.  
See also Figures S3, S4 and S5, Table S1, and STAR Methods. 
 
Figure 5. Rapidly-cycling isthmus progenitors can maintain long-term self-renewal potential. 
(A) Schematic showing the fluorescence signal associated with each phase of the cell cycle in the 
Rosa26-Fucci2a mouse. 
(B) Representative confocal images of stomach corpus gland sections (150 µm) of Rosa26-Fucci2a 
mice. Red: hCdt1-mCherry(30/120 - G1); Green: hGem(1/110 - S/G2/M); Grey: β-Catenin (I), Ki67 (II), 
HKATPase (III). Scale bars: 50 µm. 
(C) Venn diagram showing the overlap between genes more highly expressed in isolated proliferative 
isthmus cells and genes down-regulated following 5-FU treatment, taken to be prospective candidate 
markers for proliferating isthmus cells. 
(D) Immunohistochemical staining for Ki67, counterstained with Mayer’s Haematoxylin (leftmost 
panel). In situ hybridization with Stmn1 anti-sense (middle panel) and Stmn1 sense negative control 
(rightmost panel) probes in mouse stomach corpus sections. Stmn1 mRNA was restricted to the 
isthmus region delineated by Ki67 staining. Scale bar: 25 µm. 
(E) Schematic of the genetic strategy to trace Stmn1+ cell-derived progeny in the corpus gland. 
(F) Representative confocal images of the stomach corpus of Stmn1-CreERT2 mice. Red: Ki67; Green: 
eGFP; Grey: β-Catenin; Blue: DAPI. Scale bars: 50 µm. 
  
(G) Representative confocal images of 150 µm-thick sections of the stomach corpus of Stmn1-
CreERT2;R26R-tdTomato mice at 2 d, 2 w, 1 m, 3 m and 6 m post-injection of 0.5-1 mg tamoxifen/20 
g mouse body weight. Labeling of clones in the isthmus region with tdTomato can be detected as early 
as 2 d post-injection. Red: tdTomato; Grey: β-Catenin; Blue: DAPI. Scale bars: 50 µm. 
(H) Representative confocal images of the mouse stomach corpus glands of Stmn1-CreERT2;R26R-
tdTomato mice at 5 m post-labeling. Red: tdTomato for labeled cells; Grey: Atp4b for parietal cells; 
Green: Muc5ac for pit cells and GS-II for neck cells; Blue: DAPI. Scale bars: 50 µm. 
See also Figure S6 and Tables S2 and S3. 
 
Figure 6. scRNA-seq analysis defines the molecular signature and lineage relationships of actively-
cycling IsthSCs 
(A) t-SNE map showing the result of the consensus clustering (Kiselev et al., 2017) applied to scRNA-
seq data from Stmn1+ cells. Based on marker gene expression, 9 clusters were classified into 5 states 
or lineages: G1/S phase, G2/M phase, pit cell lineage (PL), neck cell lineage (NL) and secretory cell 
lineage (SL). 
(B) t-SNE maps of Stmn1+ cells showing expression of representative genes for cell proliferation 
(Stmn1, Mki67), cell cycle (Cdt1, Ccnb1) and differentiation (Muc5ac, Muc6). The color bar indicates 
normalized read counts. 
(C) Pseudotime trajectory of Stmn1+ cells inferred by Slingshot (Street et al., 2018). This algorithm 
suggests that Stmn1high cells differentiate toward two sub-lineages, pit (Stmn1low Muc5achigh) and neck 
(Stmn1low Muc6high) cells. 
(D) Expression of marker genes along the pseudotime trajectory in (C). Proliferation marker (Mki67 
and Stmn1) expression decreases along the trajectory from Stmn1high subpopulations towards 
Stmn1low Muc5achigh and Stmn1low Muc6high subpopulations. Muc5ac expression increases and Muc6 
expression decreases along the path towards pit cell identity (upper panel) and vice versa towards 
neck cell identity (lower panel), reflecting bipotential differentiation of progeny derived from IsthSCs. 
Gene expression is represented as auto-scaled, normalized read counts. 
(E) Consensus matrix from SC3 clustering that justifies the identification of 6 subclusters (S1 to S6) 
from the Stmn1high cluster (upper left in B). Similarity 0 (blue) in the color bar means that the two cells 
are always assigned to distinct clusters, whereas similarity 1 (red) means that the two cells are always 
assigned to the same cluster. 
(F) UMAP map showing the 6 subclusters (S1 to S6) of the Stmn1high cluster. Based on marker gene 
expression, S2 and S3 are primed towards the pit cell lineage (PL), whereas S6 are primed towards the 
neck cell lineage (NL). 
(G) Scatter plots of the correlation with the representative pit cell (Pit cell correlation) and neck cell 
(Neck cell correlation) for the 6 subclusters S1 to S6. The p-values from the binomial test indicate the 
statistical significance of the bias of the correlations of a cluster between pit cell and neck cell lineages. 
(H) The subclusters S1 to S6 in the pseudotime trajectory inferred by Slingshot where undifferentiated 
IsthSCs are primed toward early sublineage-restricted progenitors. NL: neck cell lineage; PL: pit cell 
lineage. 
  
(I) Gene expression trajectories along the pseudotime trajectory for two lineages. The lineages S4-S5-
S1-S2-S3 and S4-S5-S1-S6 are pit cell and neck cell lineages, respectively. The represented expression 
values are normalized read counts followed by the z-transform. The subcluster ID of cells are denoted 
by colors along the pseudotime orders in the bar on the x-axis. Muc5ac and Muc6 show opposite 
behaviors in the two lineages. The expression of Cib1, Ndufb8 and Psma7 is highest at the start of 
pseudotime and decreases along the trajectory leading to early sublineage restriction. 
(J) Examples of undifferentiated IsthSCs and early sublineage restricted progenitors in the isthmus 
region of the mouse stomach corpus glands based on mRNA expression detected by RNAscope. Red: 
Muc5ac; Green: Muc6; Grey: Ki67; Blue: DAPI. ‘Ki67+Muc5achigh’, ‘Ki67+Muclow’ and ‘Ki67+Muc6high’ 
indicate 1) Ki67+ cells expressing Muc5ac at high levels (PL progenitor), 2) Ki67+ cells expressing both 
Muc5ac and Muc6 at low levels, but not zero (IsthSC), and 3) Ki67+ cells expressing Muc6 at high levels 
(NL progenitor). 
See also Figure S7 and Table S4. 
 
Figure 7. The gastric corpus is maintained by two stem cell populations  
Schematic of the mouse gastric corpus gland. The gastric corpus is compartmentalized into base and 
isthmus regions maintained by two discrete stem cell populations. IsthSCs are multipotent and actively 
cycling, maintaining the pit-isthmus-neck regions through a process of stochastic self-renewal. IsthSCs 
reside in a narrow zone between the pit and neck regions and are characterised by co-expression at 
low levels of the differentiation markers Muc5ac and Muc6, as well as high expression of the cell cycle 
markers Stmn1 and Ki67. As IsthSCs become displaced upwards or downwards from the stem cell 
zone, they become sublineage restricted, upregulating expression of Muc5ac or Muc6, before 
terminal differentiation into the respective cell types. The gland base is maintained by Troy+/Lgr5+ 
(chief) stem cells, which are mostly quiescent during homeostasis and persist long-term. 
See also Figure S7. 
 
 
 
  
  
STAR Methods 
Contact for Reagent and Resource Sharing 
Further information and requests for resources and reagents should be directed to, and will be fulfilled 
by, the Lead Contact, Dr. Bon-Kyoung Koo (bonkyoung.koo@imba.oeaw.ac.at). 
 
Experimental Model and Subject Details  
Animals 
All ubiquitous, inducible Cre lines (Rosa26-CreERT2, UBC-CreERT2, CAGG-CreERT2, TetO-Cre) and 
Rosa26-rtTA, Rosa26-StopFlox-Confetti and Rosa26-StopFlox-tdTomato lines were obtained from The 
Jackson Laboratory. The Rosa26-Fucci2a (MGI ID: 6193738) line was a generous gift from Dr. Richard 
Mort (Mort et al., 2014). The Mki67tm2.1(cre/ERT2)Cle (stock no: 029803) line was obtained from Dr. Hans 
Clevers (Basak et al., 2018). Stmn1-P2A-eGFP-IRES-CreERT2 targeting vectors were generated by gene 
synthesis. The DTR-T2A-dsRed cassette used for vector generation was a generous gift from Dr. Nobuo 
Sasaki (Sasaki et al., 2016). Strategy development and targeting vector generation for IRES-DTR-T2A-
dsRed constructs was performed with the help of the WT–MRC Stem Cell Institute Advanced Vector 
Design and Recombineering facility. Subsequent modifications to the resulting vector were 
implemented by In-Fusion cloning. 
 
Animal treatments 
Tamoxifen (Sigma, Cat. T5648) in corn oil was injected into mice intraperitoneally in order to induce 
lineage tracing. The dose of tamoxifen used for different lines was determined based on 
recombination efficiency in the corresponding reporter lines and was as follows (mg of tamoxifen per 
20 g of mouse body weight): 5 mg for UBC-CreERT2;Rosa26-StopFlox-Confetti; three consecutive doses 
of 0.75 mg for CAGG-CreERT2;Rosa26-StopFlox-Confetti; 3 mg for Rosa26-CreERT2;Rosa26-StopFlox-
Confetti and Muc6-DTR;Rosa26-CreERT2;Rosa26-StopFlox-Confetti; 2.5 mg for Ki67-IRES-
CreERT2;Rosa26-StopFlox-RFP; 0.5 or 1 mg for Stmn1-P2A-eGFP-IRES-CreERT2;Rosa26-StopFlox-
tdTomato. TetO-Cre;Rosa26-rtTA;Rosa26-StopFlox-Confetti mice were injected intraperitoneally with 
2 mg doxycycline (Sigma, Cat. 9891) in PBS per 20 g of mouse body weight. Parietal cell depletion was 
performed by administration by oral gavage of 7 mg DMP-777 (Matrix Scientific, Cat. 096053) per 20 
g mouse body weight. 20 ng diphtheria toxin (DT; Sigma, Cat. D0564) per 20 g of mouse body weight 
was injected intraperitoneally to ablate the neck cells of Muc6-DTR;Rosa26-CreERT2;Rosa26-StopFlox-
Confetti mice. Stomach samples were obtained from mice at different time points, as indicated, 
following either a single or three consecutive injections of tamoxifen alone or in combination with 
subsequent administration of DMP-777 or DT. All mice were group housed under specific pathogen-
free conditions and had not previously undergone any procedures. We used both male and female 
mice (8-14 weeks of age) in all our experiments: the influence of sex has not been considered in this 
study, as homeostatic tissue turnover exists in both sexes. All procedures were performed according 
to United Kingdom Home Office regulations and local animal welfare committee guidelines. 
 
Method Details 
Stomach preparation 
  
Mice were euthanized by cervical dislocation and the stomach removed by dissection. The stomach 
was cut longitudinally following the greater curvature from the intestine to the esophagus and 
subsequently spread on a piece of cardboard, using needles to hold the tissue, before fixation in 
freshly prepared 4% PFA at 4 °C overnight (O/N) (~18h) with shaking. After fixation the stomach tissue 
was washed for 3 x 30 min with PBS at 4 °C with shaking. 
 
Whole mount immunofluorescence (IF) 
Corpus whole mounts were dissected from fixed stomach samples and transferred into 1 mL blocking 
and permeabilization solution consisting of 5% DMSO, 0.5% Triton-X-100 and 2% Normal donkey 
serum (NDS) in PBS in a 1.5 mL Eppendorf tube. All subsequent incubation steps were then performed 
at 4 °C using a rotor. Whole mounts were incubated with blocking and permeabilization solution O/N. 
The following day, the blocking and permeabilization solution was replaced and the whole mount 
incubated for 7 days with primary antibody, either rabbit anti-Ki67 (1:250; A. Menarini, MP-325-
CRM1) or Alexa 647-conjugated mouse anti-E-catenin (1:200; Cell Signaling Technology, 4627S), 
diluted in blocking solution (1% DMSO, 0.5% Triton-X-100 and 2% NDS in PBS). The sample was then 
washed 6 times with fresh PBS over a 24 h period before incubating with anti-rabbit Alexa 488-
conjugated IgG (1:1000; Thermo Fisher Scientific) secondary antibody diluted in blocking solution for 
7 days. Whole mounts were washed several times with PBS and incubated with 2 µg/mL DAPI in PBS 
for 24 h. For optical clearing, samples were transferred into a 24-well plate containing 1 mL RapiClear 
1.52 (CamBioScience). To avoid tissue rolling, samples were held flat between two pieces of plastic 
mesh for O/N incubation at 4°C. To allow imaging from both sides, the whole mounts were mounted 
in RapiClear 1.52 between two class-1 cover glasses (22 x 32 mm) using a 500 µm iSpacer 
(CamBioScience).  
 
Near-native sectioning 
The corpus was dissected and embedded in 4% low melt agarose for sectioning of 100 – 150 µm thick 
near-native sections using the LEICA VT 1000S Vibratome. 
 
IF staining of near-native sections 
Near-native sections were removed from any remaining agarose using forceps and subsequently 
transferred to a 12-well plate into wells containing blocking and permeabilization solution (5% DMSO, 
0.5% Triton-X-100 and 2% NDS in PBS) and incubated O/N (~18 h) at 4 °C with shaking. The following 
day, the blocking and permeabilization solution was replaced with primary antibody diluted in 
blocking solution (1% DMSO, 0.5% Triton-X-100 and 2% NDS in PBS) and the section incubated for 72-
96 h at 4 °C. The following primary antibodies were used: rabbit anti-Ki67 (1:250; A. Menarini, MP-
325-CRM1), Alexa 647-conjugated mouse anti-E-catenin (1:200; Cell Signaling Technology, 4627S), 
rabbit anti-H+/K+ ATPase β Antibody (D-18) (1:300; Santa Cruz Biotechnology, sc-84304), mouse anti-
MUC5AC (1:300; Thermo Fisher Scientific, MA512178), Alexa 488-conjugeted Lectin GS-II (1:500, 
Thermo Fisher Scientific, L21415). Sections were subsequently washed and incubated with an 
appropriate secondary antibody and DAPI in blocking solution (1% DMSO, 0.5% Triton-X-100 and 2% 
NDS in PBS) for 48 h at room temperature with shaking. After washing for 3 x 45 min with PBS, sections 
were carefully transferred from wells to microscope slides using a brush before mounting in RapiClear 
  
1.52 (CamBioScience). Slides were sealed and stored at 4 °C in the dark before imaging by fluorescent 
microscopy. 
 
Confocal imaging 
Confocal microscopy was performed with a Leica SP5 TCS confocal microscope with 20 x dry objective 
and 1-2.5 fold digital zoom using the LAS AF software. The argon laser intensity was set to 30%. The 
X/Y resolution was set to 1024 x 1024 pixels and the Z-step size was set to 1-2.5 µm. Laser scanning 
frequency was set to 400 Hz and the line average was set to 2 or 3. Section images were processed 
and analyzed using ImageJ. Whole mount images were processed using AutoQuant X 3D 
deconvolution for subsequent analysis using Imaris software. Signal intensity was adjusted for 
analysis.   
 
Immunohistochemistry in paraffin sections  
Immunohistochemistry was performed according to standard protocols. Briefly, tissues were fixed in 
4% PFA overnight at 4 °C before paraffin embedding. Paraffin-embedded sections (5 μm) were 
rehydrated, and the epitopes were exposed using Tris/EDTA buffer. Sections were incubated in 
blocking solution (2% donkey or goat serum, 5% DMSO and 0.5% Triton-X-100 in PBS) at room 
temperature for 2 h. The following primary antibodies were used: chicken anti-EGFP (1:500, Abcam, 
ab13970), rabbit anti-Ki67 (1:250; A. Menarini, MP-325-CRM1), Alexa 647-conjugated mouse anti-β-
catenin (1:200; Cell Signaling Technology, 4627S), rabbit anti-H+/K+ ATPase β Antibody (D-18) (1:500; 
Santa Cruz, sc-84304) and Alexa 555/647-conjugated rabbit anti-ATP4b (1:200; Bioss, bs-2433R-
AF555, bs-2433R-AF647). The peroxidase-conjugated secondary antibodies used were rabbit 
EnVisionC (DAKO) for 3,3’-diaminobenzidine HRP immunohistochemistry or anti-chicken/rabbit Alexa 
488/647-conjugated IgG (1:1000; Invitrogen) for immunofluorescence.  
 
In situ hybridization in paraffin sections 
For in situ hybridization, both sense and antisense probes for Stmn1 mRNA were generated by in vitro 
transcription using DIG RNA labeling mix (Roche, Cat. 11277073910) according to the manufacturer’s 
instructions. Stomach corpus was fixed overnight in 10% formalin, dehydrated and embedded in 
paraffin. Rehydrated sections (8-12 μm) were treated with 0.2 M HCl and digested in proteinase K 
solution. Sections were then post-fixed, treated with acetic anhydride solution and hybridized with 
the indicated probes for 24-72 h at 68 °C in hybridization buffer consisting of 5 x SSC (pH 4.5), 50% 
formamide, 50 g/mL yeast transfer RNA, 0.05% CHAPS, 2% blocking powder (Roche, Cat. 
11096176001), 5 mM EDTA and 50 μg/mL heparin in DEPC treated water. Sections were washed for 3 
x 20 min at 65 °C in 2 x SSC with 50% formamide. After another wash in Tris-buffered saline containing 
0.05% Tween (TBST), sections were blocked for 30 min in TBST containing 0.5% blocking powder. 
Sections were subsequently incubated overnight at 4 °C with alkaline phosphatase-conjugated anti-
digoxigenin antibody (1:2000; Roche, Cat. 11093274910) in blocking solution. After rinsing several 
times using TBST, the coloring reaction was performed with BM purple. 
RNAscope was performed on paraffin-embedded sections according to the manufacturer’s protocol 
(RNAscope® Multiplex Fluorescent Reagent Kit v2, ACDBio, 323100). The TSA kits TSA Plus Cyanine 3 
and Cyanine 5 System (Perkin Elmer, NEL752001KT) and TSA Fluorescein System (Perkin Elmer, 
  
NEL701A001KT) were used for visualization. The following probes were used: Mm-Muc6, Mm-
Muc5ac-C2 and Mm-Mki67-C3 (1:1000, ACDBio). 
 
Cell sorting 
Stomach cell sorting was performed by the WT–MRC Stem Cell Institute Flow Cytometry Facility and 
the WT Sanger Institute Flow Cytometry Facility for bulk RNA-seq and single-cell RNA-seq data 
generation, respectively. Stomachs were prepared by carefully separating the corpus from the 
forestomach and pylorus. Corpus tissue was divided into 4 pieces of similar size and incubated in 4 mL 
dissociation solution (45 U/mL Dispase II, Thermo Fisher Scientific; 0.6 mg/mL Pancreatin, Sigma; 1x 
Penicillin/Streptomycin in DMEM high glucose, HEPES, no phenol red, Thermo Fisher Scientific) at 
37 °C with shaking at 270 rpm. After dissociation the solution becomes cloudy and corpus fragments 
appear more transparent. All subsequent steps were then performed on ice. To avoid cell loss due to 
cell adhesion to pipette or tube walls, all pipettes and tubes used for pipetting the cell suspension 
were pre-incubated with either DMEM or PBS containing FBS. To further disrupt the tissue, the cell 
suspension, including corpus pieces, was pipetted up and down several times using a 10 mL pipette. 
The cell suspension without remaining corpus pieces was then transferred to a 15 mL Falcon tube. The 
corpus pieces and the dissociation tube were then washed twice with 5 mL DMEM + 10% FBS and the 
wash solutions combined with the cell suspension for inactivation of the dissociation reaction. Cells 
were centrifuged at 300 g for 5 min and resuspended in 1% FBS in PBS. The cell suspension was filtered 
through a 100 µm cell strainer into a pre-coated 15 ml tube. The tube and filters were washed twice 
with 1 mL of 1% FBS in PBS and the cell suspension was then centrifuged a second time at 300 g for 5 
min. The supernatant was removed and the cell pellet was resuspended in 100 µL of antibody mix (1% 
FBS; 10 U/mL DNAse, Promega; 1:125 Alexa Fluor® 647-conjugated anti-mouse/human CD324 (E-
Cadherin) antibody, BioLegend) and incubated for 1 h on ice. Cells were washed with 3 mL of 1% FBS 
in PBS and filtered once more if clumps could be observed. After centrifugation at 300 g for 5 min the 
cell pellet was resuspended in 1 mL of 1% FBS and 10 U/mL DNAse in PBS for sorting. MOFLO and BD 
INFLUX systems were used for sorting in the WT–MRC Stem Cell Institute Flow Cytometry Facility and 
the WT Sanger Institute Flow Cytometry Facility, respectively. 
 
RNA purification for bulk RNA seq 
For RNA purification, cells were sorted directly into 300 µL lysis buffer (Arcturus Pico Pure RNA 
Isolation Kit). Cell lysate was snap-frozen on dry ice and subsequently stored at -80 °C. RNA purification 
was performed using the Arcturus Pico Pure RNA Isolation Kit (Life Technologies) following the 
manufacturer’s instructions. 
 
Library preparation and bulk RNA sequencing 
For single-end mRNA sequencing, RNA samples were extracted, and the integrity of the total RNA was 
confirmed using an Agilent BioAnalyzer. cDNA libraries were generated from total RNA according to 
QuantSeq 3’ mRNA-Seq FWD library preparation protocols. The library templates were amplified in 
PCR cycles, and concurrently barcoded. Purified PCR products were analysed on a BioAnalyzer using a 
DNA HS chip. The lane-mixes were prepared for all samples and subjected to single-end 100 nt 
sequencing using an Illumina HiSeq 2500 system. 
  
 
Generation of single-cell RNA-seq data  
Library preparation was performed by the Single-Cell Genomics Core Facility of the WT Sanger 
Institute. Briefly, mRNA isolated from single cells was amplified using the SMARTSeq2 protocol (Picelli 
et al., 2014). Multiplexed sequencing libraries were prepared from amplified cDNA using Nextera XT 
(Illumina) and sequenced on a HiSeq 2500 running in rapid mode.   
 
Quantification and Statistical Analysis 
Whole mount image scoring 
Mouse corpus whole mounts were prepared for confocal microscopy as described above. Clonal 
expansion was analyzed using Imaris (Bitplane) software using a 3-point pie-chart contribution scoring 
strategy in which the first point denotes the beginning of a clone, the second point denotes the center 
of the corresponding gland and the third point denotes the end of the clone when following the 
circumference of the gland clockwise. Pie-chart clone contributions were measured in the pit region, 
the isthmus (high, middle, low; labeled with Ki67+ cells) and the lowest clone position. Additionally, 
the bottom of the gland was annotated with one measurement point. The resulting matrix was 
exported and clone contribution values were extracted using Excel, Mathematica or other similar 
software. The number of mice (n), statistical testing and significance are indicated in the figure 
legends. 
 
Gland section scoring 
150 µm-thick sections were prepared and imaged as described above. Gland sections were scored 
using ImageJ. In each z-stack, one reference z-plane was chosen at approximately the 30 µm mark. 
Glands that were present within the chosen reference z-stack were subsequently analyzed for clonal 
contribution in the remaining z-stack images. Clone length and position was measured for all clones 
containing 3 or more cells. The number of mice (n), statistical testing and significance are indicated in 
the figure legends. 
 
Punctuated neutral drift model 
The theoretical model describing the clonal dynamics of labeled cells is based on an approach 
developed to determine stem cell dynamics in intestinal crypts (Lopez-Garcia et al., 2010; Snippert et 
al., 2010), which share major geometric features with stomach glands. In this framework, stem cells 
at the base of the crypt are represented by angular segments. Each of these angular segments 
represents a small angular region whose proliferative dynamics are governed by a single stem cell. 
Loss and replacement of a stem cell by a dividing adjacent stem cell occurs stochastically with a 
defined average rate 𝜆 and is represented by a segment being replaced with a copy of the neighboring 
segment (Figure 4A, upper panel). To describe the clonal dynamics observed in the multi-color Confetti 
mouse system, each segment may carry a color label representing a fluorescent marker gene. Since 
each segment has the same competitive potential, these cell fate dynamics lead to “neutral 
competition” between clones. Here we adapt this approach to describe lateral clonal expansion close 
to the vertical center of the isthmus region. 
  
As described in the main text, we extend the above model by explicitly including barrier segments that 
account for the presence of parietal cells (Figure 4A, lower panel)—this allows us to compare 
experimental scenarios with and without the depletion of parietal cells and to draw conclusions about 
their role in limiting the rate of lateral stem cell loss and replacement. These barrier segments block 
lateral expansion of clones, so that only when a barrier segment is lost does a time window open for 
lateral expansion across its former position. The basis of this model assumption relies on a key 
observation: in the vast majority of cases, clones contain parietal cells bearing the same confetti color 
after 6 m post-labelling. More precisely, when we checked 73 clones (from n=3 mice) with a 
circumferential span of more than 180q from the 6 m tracing data using Rosa26-CreERT2;R26R-
Confetti mice, all of these clones contained parietal cells bearing the same confetti color as 
neighboring cells (Figure S3E), implying that newly-generated parietal cells originate from neighboring 
IsthSCs. As we seldom observe clones containing different colored parietal cell(s) in the middle of the 
clones in the long-term, we believe that the crossing events where clone expansion occurs by 
“skipping over” the live parietal cell barrier are largely inhibited unless a parietal cell is lost.  
To estimate the number and spatial distribution of parietal cells, we used experimental images of 
cross-sections of Confetti-labeled glands in the isthmus region. We then generated statistics of the 
numbers and relative angular positions of the parietal cells in the glands, both at 2 w and 3 m post-
labeling. Counting the number of parietal cells across a large number of glands revealed a 
characteristic distribution, with most glands comprising 2 parietal cells, independent of the time point 
analyzed (dark blue bars in Figure 4B). As detailed in the main text, parietal cells are not randomly 
distributed in the glands, but instead seem to maximize the distance between neighbors (Figure S3F 
and dark blue bars in Figure 4C and S3G). In our model, we take these observations into account by a 
position-dependent probability for the birth of new barrier segments that depends on the location of 
already existing barriers, as described below. 
Model description 
In the current model, the state of the system is characterized by (i) the color label of N segments 
representing IsthSCs, and (ii) the presence or absence of barrier segments and, if present, their color 
label (Figure 4A, lower panel). Each barrier segment has an equivalent size of 𝑠B stem cell-associated 
segments. All loss and replacement processes of stem cell-associated and barrier segments are 
Poisson processes with transition rates specified below. Loss and replacement of a stem cell-
associated segment occurs with a transition rate 𝜆 and amounts to a segment being replaced by a 
copy of one of its randomly selected neighboring segments, thus inheriting its color label. Barrier 
segments are sporadically born between proliferating segments. The birth rate at a certain position 
depends on the location of already existing barriers such that barrier segments tend to be localized 
with a characteristic distance between each other. Labeling the positions between stem cell-
associated segments by the index i, the transition rate for a barrier segment to appear at a position i 
is given by 
  Ω𝑖 = 𝜔in∏
𝑗
𝜙(𝑛𝑖𝑗) , (1) 
where 𝜔in is the reference birth rate for barrier segments, j runs over the indices of all currently 
present barrier segments, 𝑛𝑖𝑗 is the number of segments between position i and barrier segment j 
(which also depends on other potentially present barrier cells between the two positions), and the 
function 𝜙 determines how the birth rate depends on the distance 𝑛𝑖𝑗. To reflect the fact that barrier 
segments are preferentially located far away from each other, 𝜙 should vanish for small distances and 
  
should be close to 1 for angular distances close to 180°. A generic function that satisfies these 
requirements and which we choose here is the Gaussian function 
 𝜙(𝑛) = e−
(𝑛−𝑁/2)2
2𝜎2  , (2) 
where 𝜎 is the characteristic length scale (measured in segments) over which the probability drops to 
zero outside an existing barrier segment, and 𝑁 2⁄  is the maximum distance between segments in the 
absence of any barrier. When born, barrier segments randomly attain the color label of one of their 
neighboring stem cell-associated segments and, once present, the loss of barrier segments occurs with 
a rate 𝜔out . Only when a barrier segment is absent can its two neighboring stem cell-associated 
segments undergo mutual loss and replacement (Figure 4A). This fully characterizes our model of 
lateral expansion in the isthmus region. Stochastic realizations of the system were computed and 
statistics performed on the model results to obtain clone size distributions and the number and angle 
distribution of barrier segments using a standard stochastic simulation algorithm (Gillespie, 1977). 
Simulating control and DMP-777 experiments 
We used this model to simulate both control and DMP-777 experiments. To simulate control 
experiments, segments were color-labeled with barrier segments fully equilibrated, i.e. with their 
steady state number and angle distribution. Each segment attained a color label with an induction 
probability 𝑝ind, which is another model parameter. To simulate DMP-777 experiments, segments 
were color-labeled in the absence of any barrier segment; during the course of the simulation, the 
barrier segment distribution then reaches its steady state in parallel with the ongoing clonal dynamics. 
Apart from the initial conditions, all parameter values are taken to be the same in control and DMP-
777 experiments. 
Determining a parameter set 
To compare our model with experimental data, we obtained a reference parameter set in two steps. 
First, we independently constrained parameters that dynamically govern the number and angle 
distribution of barrier segments. We then focused on the remaining parameters that mainly affect the 
lateral clonal expansion dynamics. 
We estimated the typical width of a parietal cell from experimental images as an equivalent of 𝑠B = 2 
stem cell-associated segments. The steady-state number and angle distribution of barrier segments 
are determined by the potential width 𝜎 and the ratio 𝑟 = 𝜔out/𝜔in of loss rate and reference birth 
rate of barrier segments. To constrain these two parameters, we compared the experimentally 
determined number distribution 𝑃B
exp(𝑛) of parietal cells with the theoretical steady-state probability 
𝑃B
theor(𝑛|𝜎, 𝑟) to find n barrier segments in a gland given the parameters 𝜎 and r. No information 
about the angle distribution was used to inform the analysis. Following a standard least-squares 
approach, we then determined the residual 𝑑(𝜎, 𝑟) = ∑𝑛(𝑃B
exp(𝑛) − 𝑃B
theor(𝑛|𝜎, 𝑟))2 between these 
two distributions (Figure S3H). Subsequently, we restricted parameter combinations (𝜎, 𝑟) to regions 
in which the residual 𝑑 was not larger than the 70-fold minimum of 𝑑 (Figure S3H), which ensured that 
the region did not exceed the upper parameter boundaries. 
Having found an independent way to constrain two parameters, we determined the remaining 
parameters, i.e. the loss-and-replacement rates 𝜆, 𝜔in  and the induction frequency 𝑝ind  (together 
with 𝜎  and r in the considered region) by a fit to average clonal properties. To strengthen the 
predictive value of the model, we used only seven data points characterizing the time-dependent 
average clone size for both control and DMP-777 experiments (Figure 4D and 4F) to fit these 
parameters. In addition to the best fit parameters, we constructed a 95% CI for each parameter using 
  
a basic bootstrap method, which consisted of resampling from experimental clone size distributions 
and refitting the model to the resampled population so that a distribution of fit parameters is obtained 
(Roff, 2006). The confidence bounds were then defined as the 2.5%- and the 97.5%-quantile of the 
parameter distribution. The corresponding fit values and confidence bounds are given in Table S1. 
Comparison with experiments 
Using the obtained parameter set as a reference, we then assessed whether the model could capture 
the experimental data. Considering the barrier segments first, we found (i) that the model fit (sky blue 
dots and lines in Figure 4B) converged to a good agreement with the observed number distribution 
and (ii) also yielded a good quantitative prediction for the angle distribution conditioned on the 
number of barrier segments in the glands (sky blue dots and lines in Figure 4C and S3G). Turning to 
the clone size distribution, we found that the model fit could capture quantitatively the average clone 
size under both control and DMP-777 conditions using the same parameter set and only different 
initial conditions, as described above. Moreover, the model also captured the overall features of the 
full clone size distribution (Figure 4E, 4G and S3J) and the number of labeled glands as a function of 
time (Figure S3K). 
 
Bulk RNA-seq data analysis 
To check the quality of sequenced reads of 100 nt length from the mRNA-seq, reads were imported 
to FastQC. Based on the FastQC results, 4 nucleotides with low base signal quality at the 3’ end and, if 
present, poly A-sequences were trimmed from the raw sequences. In addition, random primer 
sequences (~12 nucleotides) at the 5’ end were also trimmed according to instructions from the 
QuantSeq FWD manual. The trimmed reads were aligned to the mouse genome (GRCm38 from 
Ensemble) using STAR (Dobin et al., 2013) with the default parameter settings.  The aligned reads were 
indexed and sorted by samtools (Li et al., 2009). HTseq was then used to assemble the aligned reads 
to transcripts and quantify the read counts (Anders et al., 2015). The read counts were normalized 
across all samples by the trimmed mean of M-values (TMM) normalization method implemented in 
the R package edgeR (Robinson et al., 2010). Reproducibility between the samples was checked with 
the principal component analysis (PCA). All samples clustered according to their biological status, 
confirming good reproducibility between samples for each condition analyzed. To focus on candidate 
marker genes with relatively high expression, genes with normalized read counts lower than the 90th 
percentile of the whole read count distribution (~63 read counts per sample) were excluded from 
further analysis. To select genes specific to proliferating cells, genes more highly expressed in 
mVenus+ cells from the Rosa26-Fucci2a mouse when compared to E-Cadherin+ cells were defined as 
those with p < 0.05 from a negative binomial test in DESeq (Anders and Huber, 2010) and a log2 fold-
change more than 1. The number of genes meeting these criteria was 150 (Table S2).  
As another criterion, microarray data from 5-FU-treated mice was also included in the gene expression 
analysis. Briefly, 5-FU treatment was employed to deplete proliferating cells. The stomach corpus was 
collected from 5-FU-treated and untreated mice at 2 d post-treatment and used for microarray 
analysis. As the replicate number for each condition was only one sample, the ratio of gene expression 
in the 5-FU-treated sample relative to the untreated sample was calculated and a ratio of less than 
1/2 was considered to be a significant change, resulting in the identification of 136 genes that were 
highly expressed in proliferating cells in the stomach corpus (Table S3).  
Following comparison of the two independent gene lists, 54 genes present in both lists were carried 
forward for further analysis. The Human Protein Atlas (Uhlén et al., 2015) was then used to confirm 
  
gene expression in the stomach and used to check the level of protein expression of the 54 genes. 
Only genes satisfying the following two criteria were considered as plausible candidates: 1) 
‘Supported’ or ‘Approved’ in terms of reliability and 2) ‘Medium’ or ‘High’ in terms of expression level. 
The number of plausible candidate genes was 17. Based on immunostaining results available at the 
Human Protein Atlas, we further selected Stmn1 and Ki67 as the most likely prospective markers for 
proliferating cells in the gastric corpus. 
 
Single-cell RNA-seq data analysis 
Paired-end reads of both Stmn1+ and Pgc+ single cells were mapped to the Mus musculus genome 
(GRCm38) using STAR (v2.5.2b) with default parameters (Dobin et al., 2013). Splice junctions in reads 
were detected with the help of a GTF file of GRCm38 provided by Ensembl (release 90). Uniquely 
mapped reads were counted for each gene using htseq-count (v0.7.2) (Anders et al., 2015). We 
removed poor-quality cells that have greater than 10% reads mapped to mitochondrial-encoded 
genes and greater than 97% genes expressed below a detection limit of 5 read counts. As a result, 610 
Stmn1+ cells and 743 Pgc+ cells passed quality control.  
Mapped reads were normalized using pool-based sized factors that were featured in the scran (v1.6.9) 
package of R (Lun et al., 2016), which allows normalization of sparse single-cell RNA-seq data. The 
normalized counts were then log2-transformed with a pseudocount count of 1. Highly variable genes 
were identified using the decomposeVar function of the scran package with options of FDR ≤ 0.05 
and biological variability > 0.5. From the log-normalized expression matrix of highly variable genes, we 
visualized each cell in the 2-dimensional t-SNE plot (van der Maaten and Hinton, 2008) by projecting 
the expression matrix into the first 50 principal components and then by reducing the dimension of 
the projected data into 2 based on the t-SNE algorithm implemented in the Rtsne (v0.13) package of 
R with a perplexity of 50 (van der Maaten, 2014).  
For the downstream analysis of Stmn+ single-cell data, we performed a consensus clustering analysis 
with the SC3 (v1.7.7) package of R (Kiselev et al., 2017). We first estimated the number of clusters 
using the sc3_estimate_k function and grouped each cell into 9 clusters using highly variable genes. 
For each cluster, we identified marker genes using the Wilcoxon rank sum test implemented in the 
Seurat (v2.3.0) package of R with the options of adjusted P-value < 0.05 and fold change > 1.5 (Butler 
et al., 2018).  
Pseudotime analysis was conducted by first projecting the log-normalized expression matrix of marker 
genes of all clusters into 50 diffusion map coordinates using the DiffusionMap (v1.1.0) package of R 
and then by inferring differentiation trajectories based on the slingshot (v1.0.0) package of R (Street 
et al., 2018). To obtain two differentiation trajectories, the starting cluster was set to 6 and ending 
clusters were set to 1 and 2. We also performed two different pseudotime analysis methods to confirm 
the robustness of our inferred trajectories: monocle (v2.6.4) (Qiu et al., 2017) and destiny (v2.6.2) 
(Haghverdi et al., 2016). For monocle, we used the expression matrix of marker genes normalized by 
the scran size factors, reduced the dimension of the matrix to 2 using the method of DDRTree, and 
ordered cells along the trajectory with the orderCells function of the monocle package of R. For 
destiny, we calculated diffusion pseudotime (DPT) from the log-normalized expression matrix of 
marker genes. For each gene, Z-scores of gene expression were plotted using a rolling mean along 
each of the trajectories with a window size of 5% of cells.  
To correct for the effects of cell cycle on cellular heterogeneity in the Stmn1high subpopulation (cluster 
4, 5, 6 and 7 in Figure 6A), we first calculated S and G2/M scores of each cell using the CellCycleScoring 
  
function of the Seurat (v2.3.0) package of R, and then regressed out the cell cycle scores with the 
ScaleData function of the Seurat package to obtain a cell cycle corrected expression matrix (Butler et 
al., 2018). Highly variable genes were identified from the cell cycle corrected expression matrix using 
the FindVariableGenes function of the Seurat package with the options of x.low.cutoff = 0.0125, 
x.high.cutoff = 2, and y.cutoff = 2. We identified six subclusters (S1-S6) in the Stmn1high subpopulation 
using the highly variable genes with the SC3 package. We visualized each cell in the 2-dimensional 
uniform manifold approximation and projection (UMAP) (Becht et al., 2019) plot using the umap 
(v0.2.0.0) package of R with default options, where the marker genes of cluster 1 (NL), 2 (PL), and 9 
(SL) in Figure 6A were taken as an input gene set, and the second and third UMAP embeddings were 
used. To estimate the degree of the fate bias of the six subclusters to specific sublineages, we then 
defined the representative gene expression patterns for neck cells and pit cells by taking the centroids 
of clusters 1 (NL) and 2 (PL) in Figure 6A, respectively. Next we computed the similarity between each 
cell in the Stmn1high subpopulation and the representative neck cell and pit cell based on their 
expression correlation. To refine the lineage relationships between the six subclusters, we again 
performed the pseudotime analysis for S1-S6 using Slingshot. As a result, two differentiation 
trajectories inferred by the slingshot package (starting cluster set as S4 and ending clusters as S3 and 
S6) were projected into the UMAP plot. The six subclusters were merged into three groups using 
hierarchical clustering with the Spearman rank correlation based distance implemented in the amap 
(v0.8-16) package of R: S4 and S5 for stem-like group; S1, S2 and S3 for pit cell progenitor group; S6 
for neck cell progenitor group. For each group, we identified marker genes using the Wilcoxon rank 
sum test implemented in the Seurat package with the options of adjusted P-value < 0.05 and fold 
change > 1.5. The marker gene set were clustered along each trajectory with k-mean clustering (k=5) 
implemented in the pheatmap (v1.0.12) package of R after smoothing the cell cycle corrected 
expression of genes along the trajectories with the loess function of R. 
 
Data and Software Availability 
The bulk RNA-seq data from the Rosa26-Fucci2a model and single-cell RNA-seq data have been 
deposited in ArrayExpress under E-MTAB-6850 and E-MTAB-6879, respectively. 
 
Supplemental items 
Movie S1. The strategy to score lateral clone size, related to Figure 2. 
This movie demonstrates the scoring strategy to quantify lateral clone expansion by measuring the 
relative angular size of clones around the gland circumference from the whole mount image of the 
stomach corpus of Rosa26-CreERT2;R26R-Confetti mice. 
 
Movie S2. Spatial organization of Ki67+ cells and parietal cells in the isthmus region, related to Figure 
3. 
This movie shows that Ki67+ proliferating cells (in red) in the isthmus region of the mouse stomach 
corpus glands are surrounded by large, long-lived parietal cells (in green). 
 
Table S1. Parameter set for the lateral expansion model, related to STAR Methods. 
  
 
Table S2. List of genes more highly expressed in mVenus+ cells from the Rosa26-Fucci2a 
mouse, related to Figure 5. 
 
Table S3. List of genes depleted in the stomach corpus upon 5-FU treatment, related to Figure 
5. 
 
Table S4. List of genes showing distinct expression patterns along the pseudotime orders from 
IsthSC toward neck or pit cell lineage, related to Figure 6. 
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Supplemental Table and Figures
  
Figure S1. Stomach clearing and deep tissue imaging using RapiClear 1.52, related to Figure 1. 
(A) Anatomy of the mouse stomach before (left panel) and after spreading and fixation (middle panel). 
Right panel: dissection and selection of corpus for subsequent agarose embedding. #1 and #2 are both 
embedded to represent both sides of the stomach. Note: the selected corpus region is smaller than 
the actual size of the corpus to ensure corpus gland identity during analysis of labeling.  
(B) Schematic of corpus agarose embedding (one of the two corpus pieces shown in (A) is depicted). 
Entire glands can be obtained by sectioning to generate 150 µm-thick sections. 
(C) Stomach tissue is rendered transparent after 4 h incubation in RapiClear 1.52.  
(D) Deep tissue imaging of nuclear H2B-GFP, in combination with matched refractive index optical 
tissue clearing. Whole mount and 150 µm-thick sections of a mouse stomach expressing nuclear-
localized GFP were imaged by conventional single photon microscopy with the exact same laser and 
confocal settings between samples mounted in RapiClear 1.52 and samples mounted in standard 
mounting medium. Our deep tissue imaging combined with tissue clearing enables us to recover the 
precise location of individually-labeled cells to assess both the horizontal and vertical intra-glandular 
clonal expansion patterns. 
 

  
Figure S2. Screening of available ubiquitous, inducible Cre recombinase mouse models crossed with 
the R26R-Confetti reporter line, related to Figure 1.  
(A-D) Four available mouse models expressing tamoxifen- or doxycycline-inducible Cre recombinase 
under the control of the indicated ubiquitous promoters were crossed with the R26R-Confetti reporter 
line (A: CAGG-CreERT2, B: Rosa26-CreERT2, C: Rosa26-rtTA;TetO-Cre, D: UBC-CreERT2) to find the 
optimal line for clonal density labeling. 150 µm-thick mouse corpus sections were stained for β-
Catenin as a membrane marker for better gland visualization (Grey). Nuclei were stained with DAPI 
(Blue). Analysis of uninduced mice demonstrated leaky Cre activity in the base of the corpus glands in 
CAGG-CreERT2 mice (A; white arrow heads). Rosa26-CreERT2 and Rosa26-rtTA;TetO-Cre mice showed 
no evidence of recombination at the confetti locus in the absence of tamoxifen or doxycycline 
administration, respectively (B, C). Induction of Cre recombinase resulted in labeled clonal expansion 
in the isthmus region by 2 w post-administration in all mouse models tested (A, B, C, D; green arrow 
heads). Isthmus-derived clones remained restricted to the pit, isthmus and neck region and did not 
reach the base of corpus glands up to 3 m post-induction (A, B, C, D). Cells located in the base of corpus 
glands were successfully labeled at 2 w post-induction to varying degrees in all mouse models tested 
and clones remained small up to 3 m post-induction (red arrow heads). Rosa26-rtTA;tetO-Cre;R26R-
Confetti and UBC-CreERT2;R26R-Confetti lines were not optimal due to their additional transgene 
requirement and lower labeling efficiency, respectively (C and D). Thus, we chose to focus on the 
Rosa26-CreERT2;R26R-Confetti mouse line in all subsequent experiments. Yellow: EYFP; Red: tdimer2; 
Cyan: mCerulean; Grey: β-Catenin; Blue: DAPI. Scale bars: 100 µm.  
(E) A representative image showing random labeling in the stomach corpus gland of Rosa26-
CreERT2;R26R-Confetti mice at 2 d post-induction (p.i.). Yellow: EYFP; Red: tdimer2; Cyan: mCerulean; 
Grey: β-Catenin; Blue: DAPI. Scale bar: 100 µm.  
(F) Corresponding plot of clone length and position scaled by gland length along the axis of the gland 
shows the random labeling in the stomach corpus gland at the same 2 d time point. 108 clones from 
n=2 mice were analyzed. 
(G, H) The relative lengths of the base clones (G) and upper clones (H) over time in Rosa26-
CreERT2;R26R-Confetti. A clone is considered to be a base clone if the relative position of the clone 
center is below 0.3. Otherwise, the clone is considered to be an upper clone. Note that the positions 
of the gland bottom and top are 0 and 1, respectively. Approx. 100 clones from n=2 mice were used 
per time point. Red line: mean; red-shaded box: 95% CI; blue-shaded box: SD. N.S.: statistically not 
significant (p-value > 0.1); *p-value < 0.05; **p-value < 0.01; ****p-value < 1e-9 (two-sample 
Kolmogorov-Smirnov test used). 
(I) Representative image of Rosa26-rtTA;TetO-Cre;R26R-Confetti mouse stomach corpus glands 
showing the maintenance of the two compartments at 3 m following induction with doxycycline. 
Yellow: EYFP; Red: tdimer2; Cyan: mCerulean; Blue: DAPI. Scale bars: 100 µm.  
(J) Scatter plot of relative (vertical) clone length and clone center position in Rosa26-rtTA;TetO-Cre; 
R26R-Confetti line at the same time point as (I). Clone characteristics illustrate that a separation over 
time into larger clones (inside red dotted ellipse) in the isthmus/pit region and smaller clones (inside 
yellow dotted ellipse) in the base region of corpus glands is maintained even in the doxycycline-
inducible Rosa26-rtTA;TetO-Cre;R26R-Confetti line, supporting the existence of the two 
compartments regardless of any tamoxifen-induced damage. Grey dots: relative clone length and 
center positions in Rosa26-CreERT2;R26R-Confetti at 3 m post-labelling by tamoxifen. n=2 mice for the 
  
Rosa26-CreERT2;R26R-Confetti model and n=1 mouse for the Rosa26-rtTA;TetO-Cre;R26R-Confetti 
model; approx. 100 clones analyzed for each model. 
 

  
Figure S3. Parietal cells establish a barrier inhibiting the lateral expansion of isthmus clones, related 
to Figure 2, 3, and 4. 
(A) Fit of simulated data to experimentally-derived measurements of relative angular clone size and 
survival curve of isthmus-labeled glands. The box plots (left graph) and green dots (right graph) 
represent experimental data. The solid line is the fit of the data generated using the orthodox neutral 
drift model. 
(B) Immunohistochemical staining for HKATPase counterstained with Mayer’s Haematoxylin at 
multiple time points following DMP-777 treatment of mouse stomach corpus sections. Scale bars: 100 
µm. 
(C) Quantification of HKATPase+ cells (viz. parietal cells) per gland in the control and at 1 d post-DMP-
777 treatment. Data are presented as mean ± SD. *** p < 0.0001 (t-test). Parietal cells were counted 
from ~15 glands of n=1 mouse at each time point. 
(D) Representative confocal images of stomach corpus from Rosa26-CreERT2;R26R-Confetti mice at 1 
m post-labeling with and without DMP-777 administration. Upper and lower clones are indicated by 
arrow heads (green: clones in the isthmus/pit; red: clones in the base). Yellow: EYFP; Red: tdimer2; 
Cyan: mCerulean; Grey: β-Catenin; Blue: DAPI. Scale bars: 50 μm. 
(E) Representative whole mount image of stomach corpus tissue from Rosa26-CreERT2;R26R-Confetti 
mice at 6 m post-tamoxifen administration. Parietal cells (indicated by dotted white lines) are labeled 
with the same confetti color as neighboring isthmus cells. Red: tdimer2; Grey: β-Catenin; Blue: DAPI. 
Scale bars: 50 μm. 
(F) Representative whole mount image of stomach corpus tissue from Rosa26-CreERT2;R26R-Confetti 
mice at 6 m post-tamoxifen administration. Parietal cells (indicated by dotted white lines) show a 
maximum angular distribution within the circumference of the glands. Red: tdimer2; Green: Ki67; 
Grey: β-Catenin; Blue: DAPI. Scale bar: 50 μm. 
(G) Distribution of minimum relative angular distance between parietal cells for 3 parietal cells per 
gland isthmus region. The minimum angular distance is the smallest angle between a pair of PCs. The 
modal distance is around 120°. 177 glands from n=2 mice were analyzed. 
(H) Residual values from the standard least-square approach in the parameter space of (", $). " is the 
characteristic length scale (in segments) over which the probability drops to zero outside an existing 
barrier segment.  $ = '()*/',- represents the ratio of the loss rate and reference birth rate of barrier 
segments. The parameter combination was restricted to the regions in which the residual . was not 
larger than the 70-fold minimum of . (dark blue region), which ensured that the region did not exceed 
the upper parameter boundaries. 
(I) Relative angular clone size of isthmus-derived clones at 1 m, 3 m and 6 m post-induction following 
administration of DMP-777. Black dots represent the measurements from individual clones. Red dots 
are the average values for each time point, with the dotted line linking the average values to show the 
trend over time. Measurements at all time points were obtained from n=3 mice. 
(J) Cumulative fraction of the relative angular clone size in control samples at 12 m post-induction. 
Dots indicate the frequency as determined from experimental data. The line indicates the fit of 
simulated results from the punctuated neutral drift (PND) model with incorporation of PCs as physical 
barriers and only different initial conditions. Shading displays the 95% CI around the fit of simulated 
data.  
  
(K) Fit of simulated data to the survival curve for isthmus-labeled glands. Dots indicate the frequency 
as determined from experimental data. The line indicates the fit of simulated results from the PND 
model.  
 

  
Figure S4. The orthodox neutral drift model and punctuated neutral drift model produce different 
predictions about the effect of perturbed parameters on vertical and lateral clone expansion, related 
to Figure 4. 
(A) Hypothetical gland structure without any physical barriers that follows the orthodox model of stem 
cell loss/replacement in glandular epithelia. This schematic corresponds to the clonal labeling state 
(by yellow) soon after clone induction (e.g. 2 d post-induction).  
(B and C) These schematics correspond to the labeling state at a few months post-labelling under 
different conditions. In (C), the IsthSC proliferation rate is faster than that in (B), resulting in an 
increased loss/replacement rate.  
(D) Time evolution of the average relative angular clone size depending on different loss/replacement 
rates (l) of IsthSCs in (B) (black line) and (C) (red line). Black line: reference value of l (= l0) from data 
fitting with the orthodox model during homeostasis; red line: 3 x l0.  
(E) Gland structure around the isthmus region of the gastric corpus gland. Green: parietal cells. This 
corresponds to the clonal labeling state (by yellow) soon after clone induction (e.g. 2 d post-induction).  
(F, G and I). These schematics correspond to the labeling state at a few months post-labelling under 
different conditions. With reference to (F) as the control case, (G) corresponds to increased 
proliferation of IsthSCs, whereas (I) corresponds to decreased parietal cell life span. (G) and (I) denote 
accelerated vertical and lateral expansion under the aforementioned conditions, respectively.  
(H) The evolution of averaged relative angular clone size depending on different loss/replacement 
rates (l) of IsthSCs in (F) (black line) and (G) (red line). Black line: reference value of l (= l1) from data 
fitting with the punctuated model; red line: 3 x l1  
(J) The evolution of averaged relative angular clone size depending on different rates (w) of parietal 
cell death in the isthmus section in (F) (black line) and (I) (blue line). Black line: reference value of w (= 
w0) from data fitting with the punctuated model; blue line: 3 X w0. 
 
 

  
Figure S5. Injury experiments using Muc6-DTR;Rosa26-CreERT2;R26R-Confetti mice confirm the 
punctuated neutral drift model, related to Figure 4. 
(A) Schematic of the Muc6-IRES-DTR-T2A-dsRed (abbr. Muc6-DTR) construct. 
(B) Confocal image of 100 µm-thick section of Muc6-DTR mouse stomach corpus. Red: Muc6-dsRed; 
Blue: DAPI; Green: ATP4B. Scale bars: 100 µm. 
(C-E) Muc6-DTR mice were injected with 1 ng diphtheria toxin (DT) per 1 g of mouse body weight. 
Mouse stomach corpus samples were collected at d1, d3, d5 and d14 post-DT administration. H&E 
staining (C) shows the presence of apoptotic bodies (top panels, green arrowheads) as well as lesions 
(top panels, red arrowheads) in the neck region of corpus glands on d1 post-DT administration. PAS/AB 
staining (D) shows no significant difference in mucus secretion. Ki67 staining (E) shows increased 
numbers of Ki67+ cells in the gland neck at 3d and 5d post-mucus neck cell depletion. Orange 
arrowheads indicate base/neck-located proliferative cells. White arrowheads indicate isthmus-
located proliferative cells. Scale bars: 100 µm. 
(F) Confocal image of Muc6-IRES-DTR-T2A-dsRed mouse stomach corpus sections under control 
conditions and at d1 post-DT treatment. Blue: DAPI; Grey: β-Catenin; Red: dsRed. Scale bars: 100 µm.  
(G) Quantification of dsRed+ cells (viz. neck cells) per gland in control glands and at d1 post-DT 
treatment. Data are presented as mean ± SD. *** p < 0.0001 (t-test). Neck cells were counted from 
~15 glands of n=1 mouse at each time point. 
(H) Schematic of Muc6-DTR experiments. During homeostasis (no DT), Muc6+ neck cells (highlighted 
in red) are located close to the IsthSCs. Upon DT treatment, the neck cells are depleted while 
preserving parietal cells intact. This injury may directly stimulate the IsthSCs adjacent to the damaged 
neck cells, which would increase IsthSC proliferation. Enhanced IsthSC proliferation in the presence of 
parietal cells causes faster clone expansion in the vertical direction, but not in the lateral direction.   
 

  
Figure S6. Rapidly cycling isthmus progenitors can maintain long-term self-renewal potential, related 
to Figure 5. 
(A) Sorting strategy to isolate proliferative isthmus cells from the stomach corpus of Rosa26-Fucci2a 
mice by FACS. R1: gating for the viable cell population. R2: gating for the stomach corpus epithelium 
based on the expression of E-Cadherin. R3: gating for proliferating cells (mVenus+/mCherry-). 
(B) Schematic outlining the selection of Stmn1 as a candidate marker for IsthSCs.  
(C) Representative confocal images of the mouse stomach corpus glands of Stmn1-P2A-eGFP-IRES-
CreERT2 (Stmn1-iCre) mice without tamoxifen administration. Red: tdTomato; Grey: β-Catenin; Blue: 
DAPI. Scale bars: 100 µm. 
(D) Position of clones scaled by gland length. Clone position analysis shows the majority of Stmn1-
derived clones are located in the isthmus/pit region at 2 d post-induction. 39 clones from n=2 mice 
were analyzed. 
(E) Representative image from confocal z-stack images of Ki67-CreERT2;R26R-RFP (Ki67-iCre) mouse 
corpus sections at 6 m post-induction. Red: RFP; Grey: β-Catenin; Blue: DAPI. Scale bar: 50 µm. 
(F) Representative whole mount images of stomach corpus of Ki67-iCre mice at 3m following DMP-
777 treatment. Red: RFP; green: Ki67; grey: β-Catenin; blue: DAPI. Scale bar: 50 µm. 
(G) The percentage of partially-labeled glands in untreated and DMP-777-treated samples was 
quantified at 3 m post-induction. n=3 mice for each condition. 
(H) Sorting strategy to isolate Stmn1+ cells from the stomach corpus of Stmn1-iCre mice by FACS. R1: 
gating for the viable cell population. R2: gating for the stomach corpus epithelium based on the 
expression of E-Cadherin. R3: gating for Stmn1+ cells based on the expression of eGFP. 
 
 

  
Figure S7. Single-cell RNA-seq analysis defines the molecular signature and lineage relationships of the 
cycling IsthSC pool, related to Figure 6 and 7. 
(A-D) Gene expression overlaid onto the t-SNE map derived from Stmn1+ single-cell RNA-seq data for 
representative genes for cell proliferation (A), G1/early S phase (B), S phase (C) and G2/M phase (D). 
The color bar indicates normalized read counts. 
(E, F) Gene expression overlaid onto the t-SNE map derived from Stmn1+ single-cell RNA-seq data for 
representative genes for pit cell (E) and neck cell (F) lineages. The color bar indicates normalized read 
counts. 
(G, H) Pseudotime analysis of Stmn1+ single-cell RNA-seq data using destiny (Haghverdi et al., 2016) 
(G) and monocle (Qiu et al., 2017) (H). All three methods used (slingshot, destiny and monocle) result 
in similar pseudotime trajectories, confirming the robustness of the differentiation trajectory inferred 
from the Stmn1+ single-cell RNA-seq data. 
(I) Gene expression overlaid onto the t-SNE map for representative genes for cell proliferation, cell 
cycle and differentiation. The whole population of the t-SNE map was partitioned into Stmn1 high 
(right) and low (left) subpopulations. This partitioning was consistent with segregation based on the 
level of Mki67 expression (high and low populations). The Stmn1high subpopulation was mainly 
segregated along the different cell cycle phases into G1/early S (lower) and G2/M (upper) populations. 
The G1/early S and G2/M populations were again segregated along differentiation markers into 
Muc5achigh cells and Muc6high cells. The color bar indicates normalized read counts. 
(J) Schematic of the Pgc-IRES-DTR-T2A-dsRed (abbr. Pgc-DTR) construct. 
(K) Sorting strategy to isolate Pgc+ cells from the stomach corpus of Pgc-DTR knock-in mice by FACS. 
R1: gating for the viable cell population. R2: gating for singlets. R3: gating for Pgc+ cells based on 
expression of dsRed. 
(L) Gene expression overlaid onto the t-SNE map derived from Pgc+ single-cell RNA-seq data for 
marker genes for differentiated cell types of the mouse stomach corpus. The color bar indicates 
normalized read counts. 
(M) Gene expression overlaid onto the t-SNE map derived from Pgc+ single-cell RNA-seq data for Lgr5 
and putative isthmus stem cell marker genes in the mouse gastric corpus glands. The reported marker 
genes Sox2, Runx1, Lrig1, Mist1 (Bhlha15) and Bmi1 all show a very broad expression pattern in the 
corpus epithelial cells. The color bar indicates normalized read counts. 
 
 
 
 
 
 
 
 
  
Table S1: Parameter set for the lateral expansion model, related to STAR Methods. 
Param. Units Value Confidence 
bounds 
Description 
N  8  number of stem cell-governed segments 
λ/N² 1/month 0.3 –0.03 / +0.13 loss-and-replacement rate of stem cell-governed 
segments 
ωin 1/month 0.4 –0.13 / +0.13 reference birth rate of barrier segments 
ωout 1/month 0.25 –0.08 / +0.05 loss rate of barrier segments 
σ segments 0.3 –0.1 / +0.1 “potential width” for birth of barrier segments (see 
text) 
sB segments 2  equivalent width of barrier segments 
nC  2  number of color labels 
pind  14 % –2% / +4% induction frequency 
 
 
  
Supplemental Video_MovieS1
Click here to access/download
Supplemental Videos and Spreadsheets
Movie_S1_RosaCre_scoring_strategy.mpg
  
Supplemental Video_MovieS2
Click here to access/download
Supplemental Videos and Spreadsheets
Movie_S2_Isthmus_cells_63x_IMARIS.mpg
  
Supplemental Spreadsheet 2
Click here to access/download
Supplemental Videos and Spreadsheets
Table_S2_Proliferation_genes_FUCCI.xlsx
  
Supplemental Spreadsheet 3
Click here to access/download
Supplemental Videos and Spreadsheets
Table_S3_Proliferation_genes_5FU.xlsx
  
Supplemental Spreadsheet 4
Click here to access/download
Supplemental Videos and Spreadsheets
Table_S4_expression patterns_Stmn1 high
subclusters.xlsx
